Back to Search
Start Over
Improvement of evaluation in Chinese patients with atherosclerotic cardiovascular disease using the very-high-risk refinement: a population-based study
- Source :
- The Lancet Regional Health. Western Pacific, Vol 17, Iss , Pp 100286- (2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- Background: Continuous refinement of atherosclerotic cardiovascular disease (ASCVD) stratification has raised the definition of very-high-risk (VHR) recently, which has been underutilized in China. We aimed to identify patients at VHR and evaluate their performances in a Chinese population. Methods: A total of 9944 patients with ASCVD was continuously enrolled. Patients at VHR was identified according to 2018 AHA/ACC guideline. Median follow-up was 36.4 months. Clinical characteristics, low-density lipoprotein cholesterol (LDL-C) achievements, and the prognostic value of VHR mapping for cardiovascular events (CVEs) were evaluated. Findings: Overall, 26% (2542/9944) of patients were deemed as VHR, which were subsequently divided into two subgroups of VHR-1 [31% (779/2542)] and VHR-2 [69% (1763/2542)]. The rates of VHR were higher among patients of male (30%,2157/7268), young with age
Details
- Language :
- English
- ISSN :
- 26666065
- Volume :
- 17
- Issue :
- 100286-
- Database :
- Directory of Open Access Journals
- Journal :
- The Lancet Regional Health. Western Pacific
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.3db40a1b15f4be093f926a7d2d87da0
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.lanwpc.2021.100286